Table 2.
OXT group (N = 34) | PLC group (N = 36) | |
---|---|---|
Mean (SD) | Mean (SD) | |
T1 (in pg/mg) | 6.02 (5.24) | 3.49 (4.47) |
T2 (in pg/mg) | 45.12 (40.08) | 4.65 (11.15) |
OXT, oxytocin; PLC, placebo; SD, standard derivation; T1, time of measure 1: prior to self-administration of the nasal spray; T2, time of measure 2: after completion of the experimental trial.